Dow Down 1.44% Nasdaq Down 1.61%

Valeant Pharmaceuticals International, Inc. (VRX)

-NYQ
130.75 Down 0.45(0.34%) 1:46PM EDT - Nasdaq Real Time Price
Prev Close:131.20
Open:131.12
Bid:131.20 x 100
Ask:131.31 x 100
1y Target Est:52.38
Beta:1.22
Next Earnings Date:N/A
Day's Range:128.64 - 131.82
52wk Range:102.60 - 153.10
Volume:2,308,700
Avg Vol (3m):2,529,450
Market Cap:43.85B
P/E (ttm):N/A
EPS (ttm):-2.24
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
VRXDown 0.34%43.85B
TEVADown 1.45%45.22B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5.85
Ex-Dividend Date:10-Nov-10

Analysts

Annual EPS Est (Dec-10) :N/A
Quarterly EPS Est (Sep-10) :N/A
Mean Recommendation*:3.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback